Foundation Medicine Highlights Actionable Data from First Patient Samples Analyzed on NGS Cancer Dx | GenomeWeb

By Turna Ray

MOUNTAIN VIEW, Calif. – Following the soft launch of its next-generation sequencing based cancer diagnostic late last year, Foundation Medicine has analyzed 36 samples from patients with solid tumors and found that its test can provide information that doctors can use to make healthcare decisions.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.